Lipoprotein (a) Cholesterol, Serum
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Evaluation of increased risk for cardiovascular disease and events:
-Most appropriately measured in individuals at intermediate risk for cardiovascular disease according to the individualsâ€™ Framingham risk score
-Patients with early atherosclerosis or strong family history of early atherosclerosis without explanation by traditional risk factors should also be considered for testing
Electrophoresis, Enzyme Staining, and Densitometry
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Lp(a) Cholesterol, S